Context-specific functional module based drug efficacy prediction

BackgroundIt is necessary to evaluate the efficacy of individual drugs on patients to realize personalized medicine. Testing drugs on patients in clinical trial is the only way to evaluate the efficacy of drugs. The approach is labour intensive and requires overwhelming costs and a number of experiments. Therefore, preclinical model system has been intensively investigated for predicting the efficacy of drugs. Current computational drug sensitivity prediction approaches use general biological network modules as their prediction features. Therefore, they miss indirect effectors or the effects from tissue-specific interactions.ResultsWe developed cell line specific functional modules. Enriched scores of functional modules are utilized as cell line specific features to predict the efficacy of drugs. Cell line specific functional modules are clusters of genes, which have similar biological functions in cell line specific networks. We used linear regression for drug efficacy prediction. We assessed the prediction performance in leave-one-out cross-validation (LOOCV). Our method was compared with elastic net model, which is a popular model for drug efficacy prediction. In addition, we analysed drug sensitivity-associated functions of five drugs - lapatinib, erlotinib, raloxifene, tamoxifen and gefitinib- by our model.ConclusionsOur model can provide cell line specific drug efficacy prediction and also provide functions which are associated with drug sensitivity. Therefore, we could utilize drug sensitivity associated functions for drug repositioning or for suggesting secondary drugs for overcoming drug resistance.

[1]  Carlotta Costa,et al.  PI3K regulates MEK/ERK signaling in breast cancer via the Rac-GEF, P-Rex1 , 2013, Proceedings of the National Academy of Sciences.

[2]  R. Shoemaker The NCI60 human tumour cell line anticancer drug screen , 2006, Nature Reviews Cancer.

[3]  S. Ramaswamy,et al.  Systematic identification of genomic markers of drug sensitivity in cancer cells , 2012, Nature.

[4]  Jason W Locasale,et al.  Metabolic rewiring drives resistance to targeted cancer therapy , 2012, Molecular systems biology.

[5]  P. Sorger,et al.  Sequential Application of Anticancer Drugs Enhances Cell Death by Rewiring Apoptotic Signaling Networks , 2012, Cell.

[6]  R. Altman,et al.  Pharmacogenomics Knowledge for Personalized Medicine , 2012, Clinical pharmacology and therapeutics.

[7]  Guanming Wu,et al.  A network module-based method for identifying cancer prognostic signatures , 2012, Genome Biology.

[8]  Mike Tyers,et al.  BioGRID: a general repository for interaction datasets , 2005, Nucleic Acids Res..

[9]  Tao Zeng,et al.  Prediction of dynamical drug sensitivity and resistance by module network rewiring-analysis based on transcriptional profiling. , 2014, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[10]  Stacey Price,et al.  A Genetic Progression Model of BrafV600E-Induced Intestinal Tumorigenesis Reveals Targets for Therapeutic Intervention , 2013, Cancer cell.

[11]  A. Bauer-Mehren,et al.  Gene-Disease Network Analysis Reveals Functional Modules in Mendelian, Complex and Environmental Diseases , 2011, PloS one.

[12]  J. Engelman,et al.  Bypass Mechanisms of Resistance to Receptor Tyrosine Kinase Inhibition in Lung Cancer , 2013, Science Signaling.

[13]  Tao Xu,et al.  Target Inhibition Networks: Predicting Selective Combinations of Druggable Targets to Block Cancer Survival Pathways , 2013, PLoS Comput. Biol..

[14]  Laura M. Heiser,et al.  A community effort to assess and improve drug sensitivity prediction algorithms , 2014, Nature Biotechnology.

[15]  J. Hou,et al.  Atorvastatin overcomes gefitinib resistance in KRAS mutant human non-small cell lung carcinoma cells , 2013, Cell Death and Disease.

[16]  Nci Dream Community A community effort to assess and improve drug sensitivity prediction algorithms , 2014 .

[17]  Julio Vera,et al.  Context Sensitive Modeling of Cancer Drug Sensitivity , 2015, PloS one.

[18]  Haiyi Jiang,et al.  Overview of gefitinib in non-small cell lung cancer: an Asian perspective. , 2008, Japanese journal of clinical oncology.

[19]  Adam A. Margolin,et al.  The Cancer Cell Line Encyclopedia enables predictive modeling of anticancer drug sensitivity , 2012, Nature.

[20]  R. Sharan,et al.  Network-based prediction of protein function , 2007, Molecular systems biology.

[21]  Alexander E. Kel,et al.  TRANSFAC®: transcriptional regulation, from patterns to profiles , 2003, Nucleic Acids Res..

[22]  Mina J Bissell,et al.  Context, tissue plasticity, and cancer: are tumor stem cells also regulated by the microenvironment? , 2005, Cancer cell.

[23]  Yanli Wang,et al.  PubChem: a public information system for analyzing bioactivities of small molecules , 2009, Nucleic Acids Res..

[24]  Jose R. Caeiro Rey,et al.  Raloxifene: Mechanism of Action, Effects on Bone Tissue, and Applicability in Clinical Traumatology Practice , 2009, The open orthopaedics journal.

[25]  Xiaomei Quan,et al.  Survey: Functional Module Detection from Protein-Protein Interaction Networks , 2014, IEEE Transactions on Knowledge and Data Engineering.

[26]  Hiroyuki Ogata,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 1999, Nucleic Acids Res..

[27]  Benjamin Haibe-Kains,et al.  Research and applications: Comparison and validation of genomic predictors for anticancer drug sensitivity , 2013, J. Am. Medical Informatics Assoc..

[28]  Sourav Bandyopadhyay,et al.  Rewiring of Genetic Networks in Response to DNA Damage , 2010, Science.

[29]  Margaret Warner,et al.  Estrogen receptors: how do they signal and what are their targets. , 2007, Physiological reviews.

[30]  Gajendra P. S. Raghava,et al.  Herceptin Resistance Database for Understanding Mechanism of Resistance in Breast Cancer Patients , 2014, Scientific Reports.